PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Jun-2021 IVD Quality Control Market Top Growth Factors and Business Intelligence Markets and Markets
07-Jun-2021 Increasing R&D By Pharmaceutical & Biopharmaceutical Companies to Drive the Demand for Cardiac Safety Services MarketsandMarkets
07-Jun-2021 Pharmaceutical Contract Development and Manufacturing Market worth $146.1 billion by 2025 MarketsandMarkets
07-Jun-2021 Pharmaceutical Blockchain Market Report Up to 2030: By Visiongain Research Inc. Visiongain
07-Jun-2021 MagForce AG Supports World Brain Tumor Day and Informs about Various Patient Events to Raise Awareness for One of the Deadliest Oncological Indications MagForce AG
07-Jun-2021 DEFENCE THERAPEUTICS RETAINS THE HUS COMPREHENSIVE CANCER CENTER TO OPTIMIZE ITS ACCUM-T-DM1 ADC THERAPEUTIC Defence Therapeutics Inc.
05-Jun-2021 3 Exclusive Speaker Interviews Released ahead of Microbiology West Coast Virtual Conference in 2 weeks SMi Group
04-Jun-2021 MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL MorphoSys AG
04-Jun-2021 LINK Medical and Insife partnership combines full CRO services with powerful safety and pharmacovigilance tools LINK Medical
04-Jun-2021 Sleep Apnea Devices Industry – Global Revenue Growth Predictions MarketsandMarkets Research Private Ltd.
04-Jun-2021 Emerging Trends to Boost Global Revenue for the Medical Equipment Maintenance Market MarketsandMarkets Research Private Ltd.
04-Jun-2021 SOTIO Presents Positive Biomarker Data from DCVAC/OvCa Phase 2 Study in First Line Ovarian Cancer at the 2021 ASCO Annual Meeting B3C newswire
04-Jun-2021 VIVEbiotech launches lentiviral vector manufacturing plant for cell and gene therapy sector VIVEbiotech
04-Jun-2021 Original-Research: HAEMATO AG (von First Berlin Equity Research GmbH) HAEMATO AG
04-Jun-2021 Lynparza reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial AstraZeneca
04-Jun-2021 Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer Sanofi
04-Jun-2021 4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update 4D pharma
04-Jun-2021 Ostomy Care Market Worth USD 3.5 Billion – A Surge in Cancer Cases to Fuel Market Growth MarketsandMarkets Research Private Ltd.
03-Jun-2021 IGEA announces changes in its board and other corporate updates IGEA Pharma N.V.
03-Jun-2021 SOHM RECEIVES SEMI-ANNUAL ORDER FROM PRIVATE LABEL CUSTOMER TO BOOST ANTICIPATED REVENUE FOR 2021 Sohm, Inc.